When is Provenge an Option? | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer @ThePCRI
When is Provenge an Option? | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer  @ThePCRI
Uploaded October 2025 | Updated September 2026, 2 weeks ago
Donate to PCRI: pcri.org/donate
For more information, visit pcri.org

0:24 What is Provenge and how has it become relevant for prostate cancer?
4:23 Why aren't more African-American patients given Provenge?
6:34 Is Provenge useful for those on Active Surveillance?
7:28 Is Provenge viable for patients with a Gleason score 3+4?
8:35 What side effects might Provenge realistically cause?
9:22 Is taking Provenge out of sequence viable?
11:40 How can patients talk to their doctor about getting Provenge?
12:55 Alex's conclusions

Don't know your stage? Take the quiz: visit prostatecancerstaging.org

To learn more about prostate cancer, visit pcri.org

Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: pcri.org/join

Who we are:

The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better-individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors.
When is Provenge an Option? | #MarkScholzMD #AlexScholz #PCRI #ProstateCancerHow To Manage Your Medical Records | #MarkScholzMD #AlexScholz #PCRI #ProstateCancerChemo? Combination Therapy for #ProstateCancer | #MarkScholzMD #AlexScholz #PCRIProstate Imaging: MRIs & PSMA | Steven Raman, MD & Mark Moyad, MD, MPH | #PCRI #ProstateCancerRadiation Therapy: Long Term & Short Term Side Effects #ProstateCancer | #MarkScholzMD #AlexScholzUnderstanding Prostate Biopsy Results | #MarkScholzMD #AlexScholz #PCRIActive Surveillance, Genetic Testing & More | Matthew Cooperberg, MD & Q+A with Mark Moyad, MD #PCRIMicro-Ultrasound: New Developments in Prostate Imaging | #MarkScholzMD #AlexScholz #PCRIBPH 101: Treatments & Aquablation With Brian Helfand, MD + Q&A #MarkMoyadMD |  #PCRI #BPHNavigating Insurance Denials | Alex Scholz, PCRI CEO & Q+A with Mark Moyad, MD #PCRILife After #ProstateCancer Surgery & Hormone Therapy | Ben Nathanson & Alex Scholz #PCRISleep And Mens Health | Emmett Rice, DO & Mark Moyad, MD, MPH | #PCRI #Prostatecancer
Prostate Cancer Research Institute |

When is Provenge an Option? | #MarkScholzMD #AlexScholz #PCRI #ProstateCancer

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER